Document is current

Any future updates will be listed below

Denosumab is not associated with risk of malignancy? More evidence is needed

Crossref DOI link: https://doi.org/10.1007/s00198-021-05988-2

Published Online: 2021-08-12

Published Print: 2021-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark